| JHW | Name: | 8-cyclopropyl-2-pyridin-3-yl-[1,3]thiazolo[5,4-f]quinazolin-9-one | Formula: | C17 H12 N4 O S | SMILES: | O=C1N(C=Nc2ccc3nc(sc3c12)c4cccnc4)C5CC5 | InChi: | InChI=1S/C17H12N4OS/c22-17-14-12(19-9-21(17)11-3-4-11)5-6-13-15(14)23-16(20-13)10-2-1-7-18-8-10/h1-2,5-9,11H,3-4H2 | Definition date: | 2019-02-27 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | 8-cyclopropyl-2-pyridin-3-yl-[1,3]thiazolo[5,4-f]quinazolin-9-one |
|
| CV0 | Name: | MESOPORPHYRIN IX CONTAINING Rh | Formula: | C34 H36 N4 O4 Rh | SMILES: | CCC1=C(C)C2=Cc3n4[Rh][N]5C(=CC1=N2)C(=C(CCC(O)=O)C5=CC6=NC(=Cc4c(C)c3CC)C(=C6CCC(O)=O)C)C | InChi: | InChI=1S/C34H38N4O4.Rh/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25 | Definition date: | 2019-05-17 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 |
|
| CV3 | Name: | (3~{Z})-4-methyl-3-[[4-(trifluoromethyl)phenyl]methylidene]-1~{H}-1,4-benzodiazepine-2,5-dione | Formula: | C18 H13 F3 N2 O2 | SMILES: | CN1C(=O)c2ccccc2NC(=O)C1=Cc3ccc(cc3)C(F)(F)F | InChi: | InChI=1S/C18H13F3N2O2/c1-23-15(10-11-6-8-12(9-7-11)18(19,20)21)16(24)22-14-5-3-2-4-13(14)17(23)25/h2-10H,1H3,(H,22,24)/b15-10- | Definition date: | 2019-05-20 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | (3~{Z})-4-methyl-3-[[4-(trifluoromethyl)phenyl]methylidene]-1~{H}-1,4-benzodiazepine-2,5-dione |
|
| JJ2 | Name: | 1-[(3,4-dichlorophenyl)methyl]-5-[2-(dimethylamino)ethyl]pyrrolo[3,2-c]pyridin-4-one | Formula: | C18 H19 Cl2 N3 O | SMILES: | CN(C)CCN1C=Cc2n(Cc3ccc(Cl)c(Cl)c3)ccc2C1=O | InChi: | InChI=1S/C18H19Cl2N3O/c1-21(2)9-10-22-8-6-17-14(18(22)24)5-7-23(17)12-13-3-4-15(19)16(20)11-13/h3-8,11H,9-10,12H2,1-2H3 | Definition date: | 2019-02-27 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | 1-[(3,4-dichlorophenyl)methyl]-5-[2-(dimethylamino)ethyl]pyrrolo[3,2-c]pyridin-4-one |
|
| JJ5 | Name: | 1-[(3,4-dichlorophenyl)methyl]-7~{H}-pyrrolo[3,2-c]pyridin-4-one | Formula: | C14 H10 Cl2 N2 O | SMILES: | Clc1ccc(Cn2ccc3C(=O)N=CCc23)cc1Cl | InChi: | InChI=1S/C14H10Cl2N2O/c15-11-2-1-9(7-12(11)16)8-18-6-4-10-13(18)3-5-17-14(10)19/h1-2,4-7H,3,8H2 | Definition date: | 2019-02-27 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | 1-[(3,4-dichlorophenyl)methyl]-7~{H}-pyrrolo[3,2-c]pyridin-4-one |
|
| JJ8 | Name: | 1-[(3,4-dichlorophenyl)methyl]imidazole | Formula: | C10 H8 Cl2 N2 | SMILES: | Clc1ccc(Cn2ccnc2)cc1Cl | InChi: | InChI=1S/C10H8Cl2N2/c11-9-2-1-8(5-10(9)12)6-14-4-3-13-7-14/h1-5,7H,6H2 | Definition date: | 2019-02-27 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | 1-[(3,4-dichlorophenyl)methyl]imidazole |
|
| D0L | Name: | (2S)-2-[[(2S)-1-heptylpyrrolidin-2-yl]carbonylamino]-3-phenyl-propanoic acid | Formula: | C21 H32 N2 O3 | SMILES: | CCCCCCCN1CCC[CH]1C(=O)N[CH](Cc2ccccc2)C(O)=O | InChi: | InChI=1S/C21H32N2O3/c1-2-3-4-5-9-14-23-15-10-13-19(23)20(24)22-18(21(25)26)16-17-11-7-6-8-12-17/h6-8,11-12,18-19H,2-5,9-10,13-16H2,1H3,(H,22,24)(H,25,26)/t18-,19-/m0/s1 | Definition date: | 2019-05-29 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | (2~{S})-2-[[(2~{S})-1-heptylpyrrolidin-2-yl]carbonylamino]-3-phenyl-propanoic acid |
|
| VMC | Name: | 2-methoxy-4-(1-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-4-phenyl-1H-imidazol-5-yl)phenol | Formula: | C23 H27 N3 O2 | SMILES: | Oc1c(OC)cc(cc1)c2n(cnc2c3ccccc3)CCC4N(CCC4)C | InChi: | InChI=1S/C23H27N3O2/c1-25-13-6-9-19(25)12-14-26-16-24-22(17-7-4-3-5-8-17)23(26)18-10-11-20(27)21(15-18)28-2/h3-5,7-8,10-11,15-16,19,27H,6,9,12-14H2,1-2H3/t19-/m0/s1 | Definition date: | 2019-09-06 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | 2-methoxy-4-(1-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-4-phenyl-1H-imidazol-5-yl)phenol |
|
| MI9 | Name: | Oxomolybdenum Mesoporphyrin IX | Formula: | C34 H36 Mo N4 O5 | SMILES: | CCC1=C(C)C2=NC1=Cc3n4c(C=C5N=C(C=C6[N](C(=C2)C(=C6CCC(O)=O)C)[Mo]4=O)C(=C5C)CCC(O)=O)c(CC)c3C | InChi: | InChI=1S/C34H38N4O4.Mo.O/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25 | Definition date: | 2019-03-12 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 |
|
| MNZ | Name: | (4~{a}~{R},5~{S},6~{R},8~{S},8~{a}~{R})-5-[2-(furan-3-yl)ethyl]-5,6,8~{a}-trimethyl-8-oxidanyl-3,4,4~{a},6,7,8-hexahydronaphthalene-1-carboxylic acid | Formula: | C20 H28 O4 | SMILES: | C[CH]1C[CH](O)[C]2(C)[CH](CCC=C2C(O)=O)[C]1(C)CCc3cocc3 | InChi: | InChI=1S/C20H28O4/c1-13-11-17(21)20(3)15(18(22)23)5-4-6-16(20)19(13,2)9-7-14-8-10-24-12-14/h5,8,10,12-13,16-17,21H,4,6-7,9,11H2,1-3H3,(H,22,23)/t13-,16-,17+,19+,20+/m1/s1 | Definition date: | 2019-10-18 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | (4~{a}~{R},5~{S},6~{R},8~{S},8~{a}~{R})-5-[2-(furan-3-yl)ethyl]-5,6,8~{a}-trimethyl-8-oxidanyl-3,4,4~{a},6,7,8-hexahydronaphthalene-1-carboxylic acid |
|
| T2C | Name: | (2S)-1,3-thiazolidine-2-carboxylic acid | Formula: | C4 H7 N O2 S | SMILES: | C1(C(O)=O)NCCS1 | InChi: | InChI=1S/C4H7NO2S/c6-4(7)3-5-1-2-8-3/h3,5H,1-2H2,(H,6,7)/t3-/m0/s1 | Definition date: | 2019-09-25 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | (2S)-1,3-thiazolidine-2-carboxylic acid |
|
| EAR | Name: | ethyl 2-[2-(4-chlorophenyl)-7-methyl-5-oxidanylidene-imidazo[1,2-a]pyrimidin-8-yl]ethanoate | Formula: | C17 H16 Cl N3 O3 | SMILES: | CCOC(=O)CN1C(=CC(=O)n2cc(nc12)c3ccc(Cl)cc3)C | InChi: | InChI=1S/C17H16ClN3O3/c1-3-24-16(23)10-20-11(2)8-15(22)21-9-14(19-17(20)21)12-4-6-13(18)7-5-12/h4-9H,3,10H2,1-2H3 | Definition date: | 2019-12-04 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | ethyl 2-[2-(4-chlorophenyl)-7-methyl-5-oxidanylidene-imidazo[1,2-a]pyrimidin-8-yl]ethanoate |
|
| QMG | Name: | 3-(6-acetylpyrrolo[1,2-a]pyrimidin-8-yl)-N-cyclopropyl-4-methylbenzamide | Formula: | C20 H19 N3 O2 | SMILES: | C1C(C1)NC(c4ccc(C)c(c2cc(C(C)=O)n3c2nccc3)c4)=O | InChi: | InChI=1S/C20H19N3O2/c1-12-4-5-14(20(25)22-15-6-7-15)10-16(12)17-11-18(13(2)24)23-9-3-8-21-19(17)23/h3-5,8-11,15H,6-7H2,1-2H3,(H,22,25) | Definition date: | 2019-11-20 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | 3-(6-acetylpyrrolo[1,2-a]pyrimidin-8-yl)-N-cyclopropyl-4-methylbenzamide |
|
| QYA | Name: | 2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(4-sulfamoylphenyl)acetamide | Formula: | C12 H12 N4 O5 S | SMILES: | C1=CC(NC(N1CC(Nc2ccc(cc2)S(N)(=O)=O)=O)=O)=O | InChi: | InChI=1S/C12H12N4O5S/c13-22(20,21)9-3-1-8(2-4-9)14-11(18)7-16-6-5-10(17)15-12(16)19/h1-6H,7H2,(H,14,18)(H2,13,20,21)(H,15,17,19) | Definition date: | 2020-01-15 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | 2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-N-(4-sulfamoylphenyl)acetamide |
|
| MXJ | Name: | (3S,5R)-5-amino-N~3~-(4-chloro-3-fluorophenyl)-N~1~-propylpiperidine-1,3-dicarboxamide | Formula: | C16 H22 Cl F N4 O2 | SMILES: | CCCNC(=O)N2CC(C(Nc1cc(F)c(Cl)cc1)=O)CC(C2)N | InChi: | InChI=1S/C16H22ClFN4O2/c1-2-5-20-16(24)22-8-10(6-11(19)9-22)15(23)21-12-3-4-13(17)14(18)7-12/h3-4,7,10-11H,2,5-6,8-9,19H2,1H3,(H,20,24)(H,21,23)/t10-,11+/m0/s1 | Definition date: | 2019-04-24 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | (3S,5R)-5-amino-N~3~-(4-chloro-3-fluorophenyl)-N~1~-propylpiperidine-1,3-dicarboxamide |
|
| LJ8 | Name: | (2~{S})-5-azanyl-2-[[[(3~{S})-3-methyl-5-phenyl-pentyl]-oxidanyl-phosphoryl]methyl]-5-oxidanylidene-pentanoic acid | Formula: | C18 H28 N O5 P | SMILES: | C[CH](CCc1ccccc1)CC[P](O)(=O)C[CH](CCC(N)=O)C(O)=O | InChi: | InChI=1S/C18H28NO5P/c1-14(7-8-15-5-3-2-4-6-15)11-12-25(23,24)13-16(18(21)22)9-10-17(19)20/h2-6,14,16H,7-13H2,1H3,(H2,19,20)(H,21,22)(H,23,24)/t14-,16+/m0/s1 | Definition date: | 2019-08-19 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | (2~{S})-5-azanyl-2-[[[(3~{S})-3-methyl-5-phenyl-pentyl]-oxidanyl-phosphoryl]methyl]-5-oxidanylidene-pentanoic acid |
|
| LMH | Name: | glucosyl-dolichol phosphate | Formula: | C31 H55 O9 P | SMILES: | C[CH](CCO[P](O)(=O)O[CH]1O[CH](CO)[CH](O)[CH](O)[CH]1O)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C | InChi: | InChI=1S/C31H55O9P/c1-22(2)11-7-12-23(3)13-8-14-24(4)15-9-16-25(5)17-10-18-26(6)19-20-38-41(36,37)40-31-30(35)29(34)28(33)27(21-32)39-31/h11,13,15,17,26-35H,7-10,12,14,16,18-21H2,1-6H3,(H,36,37)/b23-13+,24-15-,25-17-/t26-,27+,28+,29-,30+,31-/m0/s1 | Definition date: | 2019-08-25 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | [(2~{S},3~{R},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl] [(3~{S},6~{Z},10~{Z},14~{E})-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraenyl] hydrogen phosphate |
|
| K8T | Name: | 2-(3-oxidanyl-2-oxidanylidene-pyridin-1-yl)-~{N}-[2-(4-phenylphenyl)ethyl]ethanamide | Formula: | C21 H20 N2 O3 | SMILES: | OC1=CC=CN(CC(=O)NCCc2ccc(cc2)c3ccccc3)C1=O | InChi: | InChI=1S/C21H20N2O3/c24-19-7-4-14-23(21(19)26)15-20(25)22-13-12-16-8-10-18(11-9-16)17-5-2-1-3-6-17/h1-11,14,24H,12-13,15H2,(H,22,25) | Definition date: | 2019-05-03 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | 2-(3-oxidanyl-2-oxidanylidene-pyridin-1-yl)-~{N}-[2-(4-phenylphenyl)ethyl]ethanamide |
|
| PKS | Name: | 2-[(2E,5E,7E,9R,10R,11E)-10-hydroxy-3,7,9,11-tetramethyltrideca-2,5,7,11-tetraen-1-yl]-6-methoxy-3-methylpyridin-4-ol | Formula: | C24 H35 N O3 | SMILES: | CC(C(O)C(C)=[C@H]C)C=C(C=CCC(=[C@H]Cc1nc(cc(O)c1C)OC)C)C | InChi: | InChI=1S/C24H35NO3/c1-8-18(4)24(27)19(5)14-17(3)11-9-10-16(2)12-13-21-20(6)22(26)15-23(25-21)28-7/h8-9,11-12,14-15,19,24,27H,10,13H2,1-7H3,(H,25,26)/b11-9+,16-12+,17-14+,18-8+/t19-,24+/m1/s1 | Definition date: | 2019-08-15 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | 2-[(2E,5E,7E,9R,10R,11E)-10-hydroxy-3,7,9,11-tetramethyltrideca-2,5,7,11-tetraen-1-yl]-6-methoxy-3-methylpyridin-4-ol |
|
| H6W | Name: | ~{N}-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-~{N}',~{N}'-dimethyl-propane-1,3-diamine | Formula: | C18 H21 N5 O2 | SMILES: | CN(C)CCCNc1ccn2ncc(c3ccc4OCOc4c3)c2n1 | InChi: | InChI=1S/C18H21N5O2/c1-22(2)8-3-7-19-17-6-9-23-18(21-17)14(11-20-23)13-4-5-15-16(10-13)25-12-24-15/h4-6,9-11H,3,7-8,12H2,1-2H3,(H,19,21) | Definition date: | 2018-11-19 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | ~{N}-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-~{N}',~{N}'-dimethyl-propane-1,3-diamine |
|
| H72 | Name: | 4-[5-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide | Formula: | C19 H16 N6 O | SMILES: | NC(=O)c1ccc(cc1)c2cnn3ccc(NCc4cccnc4)nc23 | InChi: | InChI=1S/C19H16N6O/c20-18(26)15-5-3-14(4-6-15)16-12-23-25-9-7-17(24-19(16)25)22-11-13-2-1-8-21-10-13/h1-10,12H,11H2,(H2,20,26)(H,22,24) | Definition date: | 2018-11-19 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | 4-[5-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide |
|
| RYA | Name: | (7~{R})-2-[[3,5-bis(fluoranyl)-4-oxidanyl-phenyl]amino]-5,7-dimethyl-8-prop-2-ynyl-7~{H}-pteridin-6-one | Formula: | C17 H15 F2 N5 O2 | SMILES: | C[CH]1N(CC#C)c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C1=O | InChi: | InChI=1S/C17H15F2N5O2/c1-4-5-24-9(2)16(26)23(3)13-8-20-17(22-15(13)24)21-10-6-11(18)14(25)12(19)7-10/h1,6-9,25H,5H2,2-3H3,(H,20,21,22)/t9-/m1/s1 | Definition date: | 2020-03-02 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | (7~{R})-2-[[3,5-bis(fluoranyl)-4-oxidanyl-phenyl]amino]-5,7-dimethyl-8-prop-2-ynyl-7~{H}-pteridin-6-one |
|
| RZG | Name: | methyl 4-sulfamoylbenzoate | Formula: | C8 H9 N O4 S | SMILES: | COC(=O)c1ccc(cc1)[S](N)(=O)=O | InChi: | InChI=1S/C8H9NO4S/c1-13-8(10)6-2-4-7(5-3-6)14(9,11)12/h2-5H,1H3,(H2,9,11,12) | Definition date: | 2020-03-03 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | methyl 4-sulfamoylbenzoate |
|
| RZJ | Name: | 1-methyl-3,4-dihydro-2~{H}-quinoline-7-sulfonamide | Formula: | C10 H14 N2 O2 S | SMILES: | CN1CCCc2ccc(cc12)[S](N)(=O)=O | InChi: | InChI=1S/C10H14N2O2S/c1-12-6-2-3-8-4-5-9(7-10(8)12)15(11,13)14/h4-5,7H,2-3,6H2,1H3,(H2,11,13,14) | Definition date: | 2020-03-03 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | 1-methyl-3,4-dihydro-2~{H}-quinoline-7-sulfonamide |
|
| RZS | Name: | 6-(ethylamino)pyridine-3-carbonitrile | Formula: | C8 H9 N3 | SMILES: | CCNc1ccc(cn1)C#N | InChi: | InChI=1S/C8H9N3/c1-2-10-8-4-3-7(5-9)6-11-8/h3-4,6H,2H2,1H3,(H,10,11) | Definition date: | 2020-03-03 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | 6-(ethylamino)pyridine-3-carbonitrile |
|